GlassScriptPhysician profile
Dawn S Patrick
NPI 1609234871
$3,115.37
in general payments reported to CMS, 2019-2025
13 companies · $548 in 2025
The $548 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $530 · 2023: $713 · 2024: $1,140 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,290 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,290.38 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.81 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $709.63 | 2022-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Alkermes, INC. | $611.43 | 2022-2025 | Vivitrol, Vivitrol, Aristada |
| Indivior INC. | $288.27 | 2022-2025 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $228.30 | 2025 | Uzedy |
| Janssen Pharmaceuticals, INC | $149.97 | 2024 | Invega Sustenna |
| E.R. Squibb & Sons, L.L.C. | $129.24 | 2025 | Cobenfy |
| Gilead Sciences, INC. | $105.81 | 2021-2024 | |
| Hologic Sales and Service, LLC | $55.22 | 2023-2024 | Thinprep 2000 Processor, Third Wave, Aptima |
| Abbott Laboratories | $43.14 | 2023-2024 | Eterna, Proclaim |
| Medtronic, INC. | $22.01 | 2024 | Intellis Adaptivestim |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.49 | 2023 | |
| Mylan Specialty L.P. | $14.05 | 2024 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.